Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|Unknown unknown||Advanced Solid Tumor||no benefit||Tasquinimod||Phase II||Actionable||In a Phase II trial, treatment with Tasquinimod provided no benefit in patients with advanced solid tumors, including those with hepatocellular cancer, ovarian cancer, renal cell cancer, or gastric cancer (PMID: 28798986; NCT01743469).||28798986|